CLINICAL_TRIALS
trial_result
· 2015-12-28
Clinical Trial Update: Effects of Catheter Ablation on Burden of Atrial Fibrillation (MRICEMAN) [Phase 4]
Summary
A Phase 4 clinical trial update (MRICEMAN) evaluating how catheter ablation affects the burden of atrial fibrillation. The current status of the study is UNKNOW…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Heikki Huikuri | Conditions: Atrial Fibrillation | Phase 4 | Status: UNKNOWN